Interface-Engineered Mesoporous FeB with Programmed Drug Release for Synergistic Cancer Theranostics.

MLA

Ren, Mengjuan, et al. “Interface-Engineered Mesoporous FeB with Programmed Drug Release for Synergistic Cancer Theranostics.” ACS Applied Materials & Interfaces, vol. 14, no. 32, Aug. 2022, pp. 36438–50. EBSCOhost, https://doi.org/10.1021/acsami.2c09419.

APA

Ren, M., Zhu, X., Wang, J., Chen, L., Cai, L., Zhang, J., Wang, L., Yu, Z., & Zhou, H. (2022). Interface-Engineered Mesoporous FeB with Programmed Drug Release for Synergistic Cancer Theranostics. ACS Applied Materials & Interfaces, 14(32), 36438–36450. https://doi.org/10.1021/acsami.2c09419

Chicago

Ren, Mengjuan, Xiaojiao Zhu, Junjun Wang, Lei Chen, Longxiao Cai, Jie Zhang, Lianke Wang, Zhipeng Yu, and Hongping Zhou. 2022. “Interface-Engineered Mesoporous FeB with Programmed Drug Release for Synergistic Cancer Theranostics.” ACS Applied Materials & Interfaces 14 (32): 36438–50. doi:10.1021/acsami.2c09419.